Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug

Name: Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
License: Public Domain

Boehringer Ingelheim

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes-mellitus type-2

diabetes mellitus, type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 261454
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.